Heparin was the first anticoagulant agent to be discovered and isolated for medical use, and is one of the oldest drugs still to be in widespread clinical use. Indeed, heparin remains on the WHO Model ...

If the heparin shortage goes critical, there are some steps that could mitigate the harm, as one group outlined. "Manufacturing disturbances and an outbreak of African swine fever in China are ...

The heparin frequently given before percutaneous coronary intervention (PCI) should be pushed to as early as possible in patients with ST-segment elevation myocardial infarction (STEMI), according to ...

Researchers moved one step closer to the ability to make heparin in cultured cells. Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of ...

Review the side-effects of Heparin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Leroy Hubley, 72, married for 48 years and a father of three, has lived through tragedy no one should endure once, and he did so twice in the span of a month. Bonnie Hubley, his wife, had polycystic ...

The comparative efficacy of various anticoagulation strategies has not been clearly established in patients with acute myocardial infarction who are undergoing percutaneous coronary intervention (PCI) ...

UFH is a mixture of glycosaminoglycans of varying lengths (mean 15,000 daltons; range 3000-30,000 daltons). This heterogeneity results in variable anticoagulant activity and pharmacokinetics. In fact, ...

We read with concern the analysis by Davidson et al. (Sept. 26 issue). 1 They use the pooled placebo groups from two sepsis trials, divided into two groups — patients who either were receiving heparin ...

While heparin and other blood thinners can help prevent thrombi, such anticoagulants can also disturb normal clotting ...

Congressmen Slam FDA’s Handling of Investigation Into Tainted Chinese Heparin Several members of the House Committee on Energy & Commerce are raising new concerns over the US Food and Drug ...